invivodata Named as Finalist in Pittsburgh Technology Council Tech 50 Awards
PITTSBURGH, PA – August 9, 2011–– invivodata inc.®, the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, has been recognized by the Pittsburgh Technology Council in its 2011 “Tech 50” awards. invivodata has been named a Life Sciences category finalist in the annual awards program, which honor high-growth companies in southwestern Pennsylvania’s technology sector.
Each year the Pittsburgh Technology Council’s Tech 50 awards honor those technology companies that demonstrate the strongest advancement in product or sales success, financial strength, and job growth and retention. invivodata was recognized for its commitment to delivering practical, efficient, and flexible electronic PRO (ePRO) solutions to biopharmaceutical companies who depend upon patient-centered research, and for the regulatory-proven strategic services delivered by its scientific consulting division, PRO Consulting®.
“We continue to be impressed with invivodata’s technological advances and leadership in the growing market for clinical research technologies,” said Audrey Russo, president and CEO, Pittsburgh Technology Council. “We applaud invivodata’s commitment to the field of life sciences and its contribution to growing and sustaining Pittsburgh’s technology industry.”
“We’re honored to once again receive the Tech 50 recognition and to be considered one of Pittsburgh’s leading life sciences companies,” said Doug Engfer, invivodata president and CEO. “I attribute this recognition to our dedicated staff, and their ‘can do’ approach that delights our customers while helping them strategically use patient reported data to support labeling claims, enhance market access, and meet other clinical program objectives.”
About invivodata
invivodata is the only fully-integrated PRO Solutions Organization delivering regulatory-proven strategic consulting and practical ePRO solutions to biopharmaceutical companies who depend upon patient-centered research. From crafting PRO measurement strategy to collecting PRO data electronically, invivodata helps its customers strategically use patient reported data to support labeling claims, enhance market access, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies. invivodata’s solutions have been used in over 350 clinical programs and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA. For more information, visit www.invivodata.com.
